Identifying molecular factors that predict heart events in chronic coronary artery disease
Molecular predictors of cardiovascular events and resilience in chronic coronary artery disease
This study is looking for new ways to understand and predict heart problems in people with chronic coronary artery disease, so that doctors can tailor treatments to each person’s needs and help them live healthier lives.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11091643 on NIH RePORTER |
What this research studies
This research investigates the molecular predictors of cardiovascular events and resilience in patients with chronic coronary artery disease (CAD). By utilizing a multi 'omics' approach, the study aims to uncover novel biomarkers that can better assess individual risk and resilience to CAD. This will help personalize treatment decisions and improve patient outcomes by addressing the residual risks that current assessments overlook. The research leverages data from landmark trials and a cohort study to ensure comprehensive analysis and validation of findings.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with chronic coronary artery disease who are at risk for cardiovascular events.
Not a fit: Patients without chronic coronary artery disease or those who do not have risk factors for cardiovascular events may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate risk assessments and personalized treatment strategies for patients with chronic coronary artery disease.
How similar studies have performed: Previous research has shown promise in using multi 'omics' approaches to identify biomarkers in cardiovascular diseases, suggesting potential for success in this novel investigation.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Newman, Jonathan D — New York University School of Medicine
- Study coordinator: Newman, Jonathan D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.